LONDON, UK/PITTSBURGH, US: A recently discovered peptide toxin has been identified by a team of UK and US researchers as the cause of the development of oral candidiasis, also known as oral thrush. The substance, called “Candidalysin”, which is produced by the Candida albicans fungus, was found to punch a hole into cells lining the mouth, thus triggering the immune response.
Helper immune cells then attack the otherwise harmless fungus, resulting in the painful infection, they wrote in a study published by the Science Immunology journal.
“Surprisingly little is known about how fungal immunity in the mouth operates,” said co-senior author Dr Sarah L. Gaffen from the University of Pittsburgh School of Medicine in the US, “and, until now, it was unclear why Candida does not establish an invasive infection in healthy humans.”
In their study, the researchers used a combination of human oral epithelial cells cultured in laboratory dishes and mice infected orally with Candida, to show the central importance of Candidalysin. Discovered in 2016 by Prof. Julian Naglik of King’s College London in the UK, the toxin is the first peptide toxin identified in any fungus that was found to infect humans. Understanding its role in the infection mechanism in the mouth could eventually lead to better treatments for the condition and other fungal infections, the scientists said.
They added that, despite millions of fungal infections worldwide, there are no commercially available anti-fungal vaccines.
“Our research provides vital clues to understand the immune defence network at barrier sites of the body. This knowledge may ultimately be harnessed to design antifungal vaccines,” said Naglik.
Recently awarded a large National Institutes of Health grant, Gaffen and Naglik announced their further exploration of the role of Candidalysin signalling in oral immunity in the near future.
Oral candidiasis is one of the most common fungal infections of the mouth. While it is treatable with topical medication, it often causes pain that makes it difficult for patients to eat or swallow. It is also believed to be responsible for other serious fungal infections, especially in infants and other patients with a compromised immune system, such as HIV/Aids patients, denture wearers and those on immunosuppressants, including chemotherapy and drugs to prevent the rejection of transplanted organs.
The paper, titled “Oral epithelial cells orchestrate innate Type 17 responses to Candida albicans through the virulence factor Candidalysin”, was published in Science Immunology on 3 November.
Tags:
GREAT YARMOUTH, UK: Dentures need to be taken out before a general anaesthetic is administered, doctors have warned after a 72-year-old man’s dentures ...
COPENHAGEN, Denmark: 3Shape has released a new version of 3Shape Unite, bringing cloud-based dentistry to a new level. All licences for this workflow engine...
DUNDEE, Scotland: A landmark UK study has found that stress and burn-out across the dental workforce stem largely from systemic issues, particularly within ...
LONDON, UK: In a recent press release, the British Dental Association (BDA) lamented the budget’s failure to recognise the challenges facing dental ...
Users of dental zirconia are really spoilt for choice these days. Countless manufacturers offer zirconia materials that differ in their mechanical and ...
BIRMINGHAM, UK: Behind every smile, there’s a story—an obstacle overcome, a challenge accepted, a workflow streamlined, a life changed—not just from ...
KRIENS, Switzerland: In the UK, despite significant advancements in oral health awareness, there remains a critical gap in education around interdental ...
LONDON, England: The inextricable relationship between a person’s oral and overall health has the potential to radically transform the dental industry and...
LONDON, England: A recent editorial has highlighted the meaningful collaboration between the dental profession and industry under FDI World Dental ...
SHEFFIELD, England: One crucial dimension of the UK National Health Service dental crisis is without question its impact on children and young people. As a ...
Live webinar
Thu. 2 October 2025
2:00 pm UTC (London)
Live webinar
Mon. 6 October 2025
5:30 pm UTC (London)
Live webinar
Tue. 7 October 2025
5:30 pm UTC (London)
Prof. Dr. Falk Schwendicke MDPH
Live webinar
Thu. 9 October 2025
1:00 pm UTC (London)
Dr. Priyantha Pang Lee Yek
Live webinar
Fri. 10 October 2025
10:00 am UTC (London)
Prof. Dr. Dr. Florian Stelzle
Live webinar
Fri. 10 October 2025
7:00 pm UTC (London)
Live webinar
Wed. 15 October 2025
12:00 am UTC (London)
Prof. Dr. Wael Att, Dr. Robert A. Levine DDS, FCPP, FISPPS, AOD
To post a reply please login or register